No abstract

No abstract

No abstract

This review summarized the recent progress in the synthesis, characterization, properties, photoluminescence mechanism and biological applications of carbon dots.

Previous studies have reported high serum concentrations of polybrominated diphenyl ethers in residents of an electronic waste (e-waste) dismantling site in Guiyu town, South China. In this study, serum levels of Dechlorane Plus (DP), a chlorinated flame retardant of growing concern, were measured in residents of this region, and compared to those of a matched cohort from a nearby region in Haojiang, where fishing is the dominant industry. DP was detected in all the serum samples, with concentrations ranging from 7.8 to 465 ng/g lipid (median: 42.6 ng/g) and 0.93 to 50.5 ng/g lipid (median: 13.7 ng/g) in Guiyu and Haojiang, respectively. The Pearson's correlation coefficient between DP and decabromodiphenyl ether showed a positive relationship in Guiyu (r = 0.931, p < 0.01), but no correlation in Haojiang (r = 0.321, p = 0.34). The average anti-DP fractional abundances (f(anti) ratio) were 0.58 +/- 0.11 and 0.64 +/- 0.05 for Guiyu and Haojiang, respectively (p < 0.01). Tentatively identified dechlorination product ([-Cl + H]) was found in 19/40 serum samples (11/20 for Guiyu, 8/20 for Haojiang). These results suggest that the Guiyu and Haojiang cohorts experienced different dominant exposure routes. It is also possible that DP could bioaccumulate in a stereoselective manner, and undergo dechlorination metabolism. To the best of our knowledge, this is the first study to report DP levels in human serum. Further studies are needed to confirm the results of this study.

Steroid estrogens at sub-micrograms per liter levels are frequently detected in surface water, and increasingly cause public concern of their potential impacts on ecosystems and human health. Assessing the environmental fate and risks of steroid estrogens requires accurate characterization of various physicochemical and biological processes involving these chemicals in aquatic systems. This paper reports sorption of three estrogens, 17beta-estradiol (estradiol), estrone, and 17alpha-ethinyl estradiol (EE2), by seven soil and sediment samples at both equilibrium and rate-limiting conditions. The results indicated that attainment of sorption equilibrium needs about 2 d when aqueous estrogen concentrations (C(t)s) are 25 to 50% of their solubility limits (S(W)S), but equilibrium requires 10 to 14 d when the Ct is 20 times lower than the S(W). The measured sorption isotherms are all nonlinear, with the Freundlich model parameter n ranging from 0.475 to 0.893. The observed isotherm nonlinearity correlates to a gradual increase of single-point organic carbon-normalized sorption distribution coefficient (capacity) (K(OC)) as the equilibrium estrogen concentration (Ce) decreases. At Ce = 0.5S(W), all three estrogens have log K(OC) values of 3.14 to 3.49, whereas at Ce = 0.02S(W), the log K(OC) values for estrone, EE2, and estradiol are within ranges of 3.40 to 3.81, 3.45 to 3.85, and 3.71 to 4.12, respectively. This study suggests that, when at sub-micrograms per liter levels, these estrogenic chemicals may exhibit even slower rates and greater capacities of sorption by soils and sediments.

The development of active and durable catalysts with reduced platinum content is essential for fuel cell commercialization. Herein we report that the dealloyed PtCo/HSC and PtCo3/HSC nanoparticle (NP) catalysts exhibit the same levels of enhancement in oxygen reduction activity (~4-fold) and durability over pure Pt/C NPs. Surprisingly, ex situ high-angle annular dark field scanning transmission electron microscopy (HAADF STEM) shows that the bulk morphologies of the two catalysts are distinctly different: D-PtCo/HSC catalyst is dominated by NPs with solid Pt shells surrounding a single ordered PtCo core; however, the D-PtCo3/HSC catalyst is dominated by NPs with porous Pt shells surrounding multiple disordered PtCo cores with local concentration of Co. In situ X-ray absorption spectroscopy (XAS) reveals that these two catalysts possess similar Pt–Pt and Pt–Co bond distances and Pt coordination numbers (CNs), despite their dissimilar morphologies. The similar activity of the two catalysts is thus ascribed to their comparable strain, ligand, and particle size effects. Ex situ XAS performed on D-PtCo3/HSC under different voltage cycling stage shows that the continuous dissolution of Co leaves behind the NPs with a Pt-like structure after 30k cycles. The attenuated strain and/or ligand effects caused by Co dissolution are presumably counterbalanced by the particle size effects with particle growth, which likely accounts for the constant specific activity of the catalysts along with voltage cycling.

Cancer remains one of the world's leading causes of death. However, most conventional chemotherapeutic drugs only show a narrow therapeutic window in patients because of their inability to discriminate cancer cells from healthy cells. Nanoparticle-based therapeutics (termed nanotherapeutics) have emerged as potential solutions to mitigate many obstacles posed by these free drugs. Deep insights into knowledge of the tumor microenvironment and materials science make it possible to construct nanotherapeutics that are able to release cargoes in response to a variety of internal stimuli and external triggers. Therefore, such highly sophisticated nanosystems could help impede the premature release of toxic drugs in the blood circulation or healthy tissues, thus enhancing the safety profiles of encapsulated drugs. In this context, this review offers a comprehensive overview of several specific stimuli, including internal stimuli (e.g., pH, temperature, enzyme, redox, and H O ) and external stimuli (e.g., magnetic, photo, and ultrasound). We envision that applications of these smart nanotherapeutics can benefit cancer patients and provide a good chance for clinical translation of many nanoparticle formulas. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Diagnostic Tools > Diagnostic Nanodevices Diagnostic Tools > in vitro Nanoparticle-Based Sensing.